SEC Filing Update: #ARTV Artiva Biotherapeutics, Inc. : $11.45

Sector: Healthcare | YTD: 🔼+ 166.90% The SEC disclosed Today (14-AUG-2026) that VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. has INCREASED #ARTV Shares by 26.97% 🟢 * Previous Holdings: 1.61M Shares * Current Holdings: 2.04M Shares * Increase+434.03K * Increased(%)+26.97% * Ownership: 4.2% * Estimated Investment Value: $4.92M https://www.thinksabio.com/reports/isr/ARTV The quarterly average prices of #ARTV: Q3 2025: $2.68 Q4 2025: $3.76 Q1 2026: $4.95 📌 Institutional activity in the last 30 days for #ARTV: • RA CAPITAL MANAGEMENT – Increased holdings by 604,333 shares (23-JUL-2026)